Your browser doesn't support javascript.
loading
Traumatic brain injury alters the effects of class II invariant peptide (CLIP) antagonism on chronic meningeal CLIP + B cells, neuropathology, and neurobehavioral impairment in 5xFAD mice.
Iannucci, Jaclyn; Dominy, Reagan; Bandopadhyay, Shreya; Arthur, E Madison; Noarbe, Brenda; Jullienne, Amandine; Krkasharyan, Margret; Tobin, Richard P; Pereverzev, Aleksandr; Beevers, Samantha; Venkatasamy, Lavanya; Souza, Karienn A; Jupiter, Daniel C; Dabney, Alan; Obenaus, Andre; Newell-Rogers, M Karen; Shapiro, Lee A.
Afiliação
  • Iannucci J; Department of Neuroscience and Experimental Therapeutics, College of Medicine, Texas A&M University, Bryan, TX, USA.
  • Dominy R; Department of Neuroscience and Experimental Therapeutics, College of Medicine, Texas A&M University, Bryan, TX, USA.
  • Bandopadhyay S; Department of Neuroscience and Experimental Therapeutics, College of Medicine, Texas A&M University, Bryan, TX, USA.
  • Arthur EM; Department of Neuroscience and Experimental Therapeutics, College of Medicine, Texas A&M University, Bryan, TX, USA.
  • Noarbe B; Division of Biomedical Sciences, University of California Riverside, Riverside, CA, USA.
  • Jullienne A; Division of Biomedical Sciences, University of California Riverside, Riverside, CA, USA.
  • Krkasharyan M; Division of Biomedical Sciences, University of California Riverside, Riverside, CA, USA.
  • Tobin RP; Department of Surgery, Division of Surgical Oncology, University of Colorado Anschutz Medical Campus, Denver, CO, USA.
  • Pereverzev A; Department of Neuroscience and Experimental Therapeutics, College of Medicine, Texas A&M University, Bryan, TX, USA.
  • Beevers S; Department of Neuroscience and Experimental Therapeutics, College of Medicine, Texas A&M University, Bryan, TX, USA.
  • Venkatasamy L; Department of Neuroscience and Experimental Therapeutics, College of Medicine, Texas A&M University, Bryan, TX, USA.
  • Souza KA; Department of Neuroscience and Experimental Therapeutics, College of Medicine, Texas A&M University, Bryan, TX, USA.
  • Jupiter DC; Department of Biostatistics and Data Science, Department of Orthopaedics and Rehabilitation, The University of Texas Medical Branch, Galveston, TX, USA.
  • Dabney A; Department of Statistics, College of Arts & Sciences, Texas A&M University, College Station, TX, USA.
  • Obenaus A; Division of Biomedical Sciences, University of California Riverside, Riverside, CA, USA.
  • Newell-Rogers MK; Department of Neuroscience and Experimental Therapeutics, College of Medicine, Texas A&M University, Bryan, TX, USA. mknewellrogers@tamu.edu.
  • Shapiro LA; Department of Medical Physiology, College of Medicine, Texas A&M University, Bryan, TX, USA. mknewellrogers@tamu.edu.
J Neuroinflammation ; 21(1): 165, 2024 Jun 27.
Article em En | MEDLINE | ID: mdl-38937750
ABSTRACT

BACKGROUND:

Traumatic brain injury (TBI) is a significant risk factor for Alzheimer's disease (AD), and accumulating evidence supports a role for adaptive immune B and T cells in both TBI and AD pathogenesis. We previously identified B cell and major histocompatibility complex class II (MHCII)-associated invariant chain peptide (CLIP)-positive B cell expansion after TBI. We also showed that antagonizing CLIP binding to the antigen presenting groove of MHCII after TBI acutely reduced CLIP + splenic B cells and was neuroprotective. The current study investigated the chronic effects of antagonizing CLIP in the 5xFAD Alzheimer's mouse model, with and without TBI.

METHODS:

12-week-old male wild type (WT) and 5xFAD mice were administered either CLIP antagonist peptide (CAP) or vehicle, once at 30 min after either sham or a lateral fluid percussion injury (FPI). Analyses included flow cytometric analysis of immune cells in dural meninges and spleen, histopathological analysis of the brain, magnetic resonance diffusion tensor imaging, cerebrovascular analysis, and assessment of motor and neurobehavioral function over the ensuing 6 months.

RESULTS:

9-month-old 5xFAD mice had significantly more CLIP + B cells in the meninges compared to age-matched WT mice. A one-time treatment with CAP significantly reduced this population in 5xFAD mice. Importantly, CAP also improved some of the immune, histopathological, and neurobehavioral impairments in 5xFAD mice over the ensuing six months. Although FPI did not further elevate meningeal CLIP + B cells, it did negate the ability of CAP to reduce meningeal CLIP + B cells in the 5xFAD mice. FPI at 3 months of age exacerbated some aspects of AD pathology in 5xFAD mice, including further reducing hippocampal neurogenesis, increasing plaque deposition in CA3, altering microgliosis, and disrupting the cerebrovascular structure. CAP treatment after injury ameliorated some but not all of these FPI effects.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Camundongos Transgênicos / Linfócitos B / Antígenos de Diferenciação de Linfócitos B / Antígenos de Histocompatibilidade Classe II / Lesões Encefálicas Traumáticas Limite: Animals / Humans / Male Idioma: En Revista: J Neuroinflammation Assunto da revista: NEUROLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Camundongos Transgênicos / Linfócitos B / Antígenos de Diferenciação de Linfócitos B / Antígenos de Histocompatibilidade Classe II / Lesões Encefálicas Traumáticas Limite: Animals / Humans / Male Idioma: En Revista: J Neuroinflammation Assunto da revista: NEUROLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos